SCHEMBL2370002

SCHEMBL2370002

Fc1cnc(NC2CC2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.48
KDM4E B2RXH2 1/20 0.47
GAA P10253 1/20 0.47
AOC3 Q16853 2/20 0.45
HDAC1 Q13547 3/20 0.43
HDAC3 O15379 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
ULK1 O75385 1/20 0.42
ALDH1A1 P00352 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
HTR2B P41595 1/20 0.38
MCHR1 Q99705 1/20 0.38
MAPK8 P45983 3/20 0.38
MAPK10 P53779 2/20 0.38
MAPK9 P45984 1/20 0.38
MAPK14 Q16539 1/20 0.38
PAK1 Q13153 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31334330 0.90 MAPK8 (0.47) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL22570292 0.90 MAPK1 (0.46) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL22570297 0.90 GRM5 (0.49) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL22570114 0.90 MAPK8 (0.47) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL25091274 0.86 DRD2 (0.44) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL24267578 0.86 MAPK1 (0.42) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL24267452 0.86 DRD2 (0.44) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL22570296 0.86 MAPK1 (0.42) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL24618831 0.86 MAPK1 (0.42) MAPK1KDM4EGAAAOC3HDAC1
SCHEMBL22570294 0.86 MAPK1 (0.42) MAPK1KDM4EGAAAOC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed